BEHIND KANJINTI®

IDENTICAL STORAGE AND HANDLING1

KANJINTI® Storage Details

*Multi-dose when reconstituted with Bacteriostatic Water for Injection.

*Multi-dose when reconstituted with Bacteriostatic Water for Injection.

See how the efficacy and safety of KANJINTI®‡ and
Herceptin®‡ compare.

btn-medi_rainbow-svgtotality of evidence
 

†As of [June 30, 2025]. Number of non-oncology patients calculated from duration of therapy and adherence data from IQVIA Analytics Link and IQVIA Patient Link, respectively. Number of oncology patients determined using claims data (US) and physician surveys (ex-US). Patient count estimates may not accurately reflect the actual number of patients treated with Amgen biosimilars if adherence or length of treatment in real world differs from the assumptions used.

‡EU-sourced Herceptin® was used in the LILAC study. The KANJINTI® clinical pharmacokinetic (PK) study demonstrated equivalence between EU- and US-sourced Herceptin® and KANJINTI®.

×
Amgen stands with our local Los Angeles community. Click here to learn what we are doing to support and contact us if the fires have impacted your access to Amgen medication.